Most lately, it's been determined that conolidine and the above derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in very similar places as classical opioid receptors, it binds into a wide array of endogenous opioids. Unlike most opioid receptors, this receptor functions as being a scavenger and isn't going to activate